Mesoblast LimitedNEW YORK, Oct. 02, 2022 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced today that…
[Read More]
October 02 at 7:52 pm
September 30 at 6:15 pm
Siga Technologies Inc. (SIGA) Gains As Market Dips: What You Should Know
In the latest trading session, Siga Technologies Inc. (SIGA) closed at $10.30, marking a +0.98% move from the previous day. This change outpaced the S&P…
[Read More]
September 30 at 5:50 pm
Novavax (NVAX) Dips More Than Broader Markets: What You Should Know
In the latest trading session, Novavax (NVAX) closed at $18.20, marking a -1.99% move from the previous day. This change lagged the S&P 500’s 1.51%…
[Read More]
September 30 at 12:33 pm
Athersys to Host Business Update Conference Call on October 6th
CLEVELAND, September 30, 2022–(BUSINESS WIRE)–Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today it will host a…
[Read More]
September 30 at 11:48 am
3 Healthcare Stocks to Sell Before They Die
The Fed’s key interest rate target now stands at 3%-3.25%, way up from 0%-0.25% at the beginning of the year. That means, for all companies, borrowing…
[Read More]
September 30 at 9:00 am
Applied DNA’s Biotherapeutics Subsidiary Publishes Manuscript Demonstrating that a LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial in Ferrets
– Promising Results Support Further Development of LinearDNA as a Next Generation Vaccine Platform -STONY BROOK, N.Y., September 30, 2022–(BUSINESS WIRE)–Applied DNA Sciences, Inc. (NASDAQ:…
[Read More]
September 30 at 7:33 am
BiondVax announces financial plans to support its ongoing NanoAb pipeline development
JERUSALEM, Israel , Sept. 30, 2022 /PRNewswire/ — BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) (“BiondVax”), a biotechnology company focused on developing, manufacturing, and commercializing innovative products for…
[Read More]
September 29 at 10:15 am
Morphic Holding, Inc. (MORF) Moves 7.3% Higher: Will This Strength Last?
Morphic Holding, Inc. (MORF) shares rallied 7.3% in the last trading session to close at $28.77. This move can be attributable to notable volume with…
[Read More]
September 29 at 9:45 am
These 2 Growth Stocks Have Fallen Out of Grace. Are They Buys?
Motley Fool30 Billion Reasons Why This Nasdaq Stock Is a Screaming BuyThe stock market may not look like a good place to be right now,…
[Read More]
September 29 at 9:00 am
Scilex Holding Company, a Sorrento Company, Announces Pre-Emptive Pay Off of Remaining Balance of its Senior Secured Notes
Sorrento Therapeutics, Inc.Pre-emptive pay off of the Senior Secured Notes (the “Notes”) eliminated the prior $28.0 million increase in the principal amount of the NotesPALO…
[Read More]
September 29 at 8:32 am
Siga Tech receives $10.7-mln order for antiviral Tpoxx amid monkeypox outbreak
Sept 29 (Reuters) – Siga Technologies said on Thursday it has won a new contract for its oral antiviral drug, Tpoxx, worth up to $10.7…
[Read More]
September 29 at 8:00 am
VBI Vaccines Announces Initiation of Phase 1 Study of Multivalent Coronavirus Vaccine Candidate, VBI-2901
Initiation of first clinical study of multivalent VBI-2901, designed to increase breadth of protection against COVID-19 and related coronavirusesPreclinical data support broadly reactive immunity of…
[Read More]